For the year ending 2025-12-31, OCUL made $51,951K in revenue. -$265,939K in net income. Net profit margin of -511.90%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue, net | 51,951 | 63,461 | ||
| Cost of product revenue | 6,574 | 5,626 | ||
| Research and development | 197,096 | 127,635 | ||
| Selling and marketing | 53,922 | 41,590 | ||
| General and administrative | 64,376 | 60,653 | ||
| Total costs and operating expenses | 321,968 | 235,504 | ||
| Loss from operations | -270,017 | -171,781 | ||
| Interest income | 18,355 | 20,282 | ||
| Interest expense | 11,835 | 13,577 | ||
| Change in fair value of derivative liabilities | -2,471 | -480 | ||
| Gains and losses on extinguishment of debt, net | - | -27,950 | ||
| Other gains (expenses) | 29 | - | ||
| Total other income (expense), net | 4,078 | -21,725 | ||
| Net loss | -265,939 | -193,506 | ||
| Basic EPS | -1.42 | -1.22 | ||
| Diluted EPS | -1.42 | -1.22 | ||
| Basic Average Shares | 187,241,483 | 158,265,162 | ||
| Diluted Average Shares | 187,241,483 | 158,265,162 | ||
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)